FDA Inspection 1334136 — Celltrion Pharm, Inc.
The FDA completed an inspection of Celltrion Pharm, Inc. on Aug 10, 2026 in Cheongju. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Aug 10, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cheongju (Korea (the Republic of))